Colorado Blood Cancer Institute Medical Group

Colorado Blood Cancer Institute Medical GroupColorado Blood Cancer Institute Medical GroupColorado Blood Cancer Institute Medical Group

Colorado Blood Cancer Institute Medical Group

Colorado Blood Cancer Institute Medical GroupColorado Blood Cancer Institute Medical GroupColorado Blood Cancer Institute Medical Group
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Contact Us
  • About Us
  • News and Social Media
  • Blood Blog
  • Clinical Tools
  • Research Menu

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Helpful Reference Links

LLS 3D Model Library

LLS has 3D models of treatments, diseases, and tests

Check it out

Prognostic Scoring: Plasma Cells

Amyloidosis

CIMBTR Response Criteria

Multiple Myeloma

Cardiac/Revised Mayo/Renal

Multiple Myeloma

CIMBTR Response Criteria

Multiple Myeloma

R-ISS

CIMBTR Response Criteria

CIMBTR Response Criteria

CIMBTR Response Criteria

Amyloid | Multiple Myeloma | Plasma Cell Leukemia | POEMS | WM

Prognostic Scoring: Lymphoid

Waldenstrom Macroglobulinemia

Waldenstrom Macroglobulinemia

Waldenstrom Macroglobulinemia

IPSSWM

CLL/SLL

Waldenstrom Macroglobulinemia

Waldenstrom Macroglobulinemia

CLL-IPI 

Follicular Lymphoma

Waldenstrom Macroglobulinemia

Extranodal Marginal Zone Lymphoma (MALT)

FLIPI

Extranodal Marginal Zone Lymphoma (MALT)

Extranodal Marginal Zone Lymphoma (MALT)

Extranodal Marginal Zone Lymphoma (MALT)

MALT-IPI

Mantle Cell Lymphoma

Extranodal Marginal Zone Lymphoma (MALT)

Mantle Cell Lymphoma

MIPIb

Hodgkin Lymphoma

Extranodal Marginal Zone Lymphoma (MALT)

Mantle Cell Lymphoma

IPS

Burkitt Lymphoma

Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

Factors (1 point each): age 40+, ECOG PS 2+, CNS involvement, LDH > 3 x ULN

Low: 0 | Int: 1 | High: 2-4 

Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

R-IPI 

CNS Risk

Diffuse Large B-cell Lymphoma

T-cell Lymphomas

CNS-IPI

T-cell Lymphomas

CIBMTR Response Criteria

T-cell Lymphomas

IPI

CIBMTR Response Criteria

CIBMTR Response Criteria

CIBMTR Response Criteria

ALL | CLL/SLL | Hodgkin Lymphoma | Non-Hodgkin Lymphoma

Prognostic Scoring: Autoimmune

Multiple Sclerosis

EDSS

Prognostic Scoring: Myeloid

AML

AML

AML

Low:  inv(16), t(16;16), t(8;21), t(15;17) 

Int:  normal cyto, +8, t(9;11); other chrom abn

High: -5, 5q-, -7, 7q-, 11q23, inv(3), t(3;3), t(6;9), t(9;22), 3+ chrom abn

MDS

AML

AML

R-IPSS

CML

AML

CMML

Sokal

CMML

Essential Thrombocythemia

CMML

CPSS-Mol

Essential Thrombocythemia

Essential Thrombocythemia

Essential Thrombocythemia

IPSET-Thrombosis

Polycythemia Vera

Essential Thrombocythemia

Essential Thrombocythemia

Low: < or = 60 and no prior thrombosis

High: all others

Post-PV MF

CIBMTR Response Criteria

Primary Myelofibrosis

MYSEC-PM

Primary Myelofibrosis

CIBMTR Response Criteria

Primary Myelofibrosis

MIPSS70+v2.0 

DIPSS+

CIBMTR Response Criteria

CIBMTR Response Criteria

CIBMTR Response Criteria

AML | MDS | CML 

Copyright © 2023 Colorado Blood Cancer Institute Medical Group - All Rights Reserved.

  • CBCI Members

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept